CJC-1295 without DAC 2 mg Peptide vial by Swiss Chem

Description

CJC-1295 without DAC: A Synthetic Peptide for Advanced Growth Hormone Research

CJC-1295 without DAC , also known as GHRH (1-29)-NH2, is a synthetic peptide that belongs to the class of growth hormone-releasing hormones (GHRHs). It binds to the GHRH receptor in the pituitary gland, triggering the release of growth hormones into the bloodstream. CJC-1295 is distinguished by its extended half-life, providing sustained stimulation of GH release over a longer period than other GHRHs.

Chemical Properties of CJC-1295 without DAC

• Chemical Formula: C152H252N44O42
• Molecular Mass: 3367.9
• Synonyms: GHRH (1-29)-NH2
• Molar Mass: 3367.9
• CAS Number: 446262-90-4
• PubChem: 91976842

Product Specifications

• Total Amount of Active Ingredient: 2 mg
• Shelf Life: 36 months
• Quality Guarantee: All products undergo rigorous lab testing, with results periodically published on our website. Customers can test their purchases at any HPLC-licensed facility. If the results are negative, we will refund the cost of the HPLC test, the total order amount, and the shipping fee.

Benefits of CJC-1295 without DAC

• Sustained GH Release: Provides prolonged stimulation of growth hormone release due to its extended half-life.
• Increases Muscle Mass and Strength: Studies have shown significant improvements in muscle mass and strength, particularly in older adults and patients with conditions such as cancer, COPD, and HIV/AIDS.
• Decreases Body Fat: Demonstrated potential to reduce body fat.
• Improves Skin Elasticity: Enhances skin elasticity, contributing to a more youthful appearance.
• Elevates IGF-1 Levels: Increases levels of insulin-like growth factor-1 (IGF-1), beneficial for growth hormone-deficient children and general health improvements.

CJC-1295 Without DAC

CJC-1295 without DAC (Drug Affinity Complex) is a shorter-acting form of the peptide. Unlike CJC-1295 without DAC , it does not bind to serum albumin and is rapidly cleared from the bloodstream, resulting in a shorter duration of action.

Minor Side Effects

While generally well-tolerated, some minor side effects observed in research include:

• Mild irritation at the injection site
• Temporary fatigue

Dosage Recommendations

• Beginner: 100 mcg per day
• Intermediate: 200 mcg per day
• Advanced: 300 mcg per day
• – Women: 100 mcg per day (adjust based on body weight and response)

Peer-Reviewed Studies

1. Teichman, S. L., et al. (2006). “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295 without DAC , a long-acting analog of GH-releasing hormone, in healthy adults.” The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
2. Henninge, J., et al. (2010). “Identification of CJC‐1295, a growth‐hormone‐releasing peptide, in an unknown pharmaceutical preparation.” Drug Testing and Analysis, 2(11‐12), 647-650.

Bottom Line

CJC-1295 without DAC is a powerful peptide for research focused on growth hormone-related therapies, including muscle growth, fat reduction, and overall rejuvenation. Its ability to stimulate sustained GH release positions it as a critical tool for scientific studies. Always consult with a qualified professional before incorporating new substances into research protocols.

The information presented here is not meant to replace medical advice, diagnosis, or treatment. If you have any concerns about a medical condition, it’s important to consult with your physician or a qualified healthcare professional. Never disregard or delay seeking medical advice based on what you’ve read or seen. We take no responsibility or liability for the use of our research compounds and products. Please be aware that they are exclusively intended for research purposes. We do not endorse any personal use.